|
⚲
|
| Keyboard |
| Atlas Venture Life Science Advisors LLC
✚
|
|
|---|---|
| CRD # | 174766 |
| SEC # | 802-81032 |
| CIK # | 0001917529 |
| AUM | |
| Employees | |
| Phone | 857-201-2700 |
| Address | 300 Technology Square Cambridge, MA 02139 |
| Source | [IAPD] [EDGAR] [Website] |
| Total AUM ($) |
|---|
| Sector | Form 13F Holdings | Value ($M) | |
|---|---|---|---|
| Kymera Therapeutics Inc | 381.3 | ||
| Dyne Therapeutics Inc | 165.5 | ||
| Sionna Therapeutics Inc | 120.1 | ||
| FS Development Corp | 96.8 | ||
| Homology Medicines Inc | 13.4 | ||
| Frequency Therapeutics Inc | 12.9 | ||
| Holdings by Sector ($M) |
|---|
| Type | Form D Funds | Date | Sold | AUM |
|---|---|---|---|---|
| VC | Atlas Venture Opportunity Fund III LP | [2026-03-31] | 400.0 M | 399.0 M |
| Offered $400,000,000 · Filed 2025-09-04 (D) · Exemption 506(b), 3(c), 3(c)(7) · Duration One year or less · Revenue Not Applicable | ||||
| VC | Atlas Venture Fund XIV LP | [2025-04-01] | 450.0 M | 452.0 M |
| Offered $450,000,000 · Filed 2024-12-05 (D) · Exemption 506(b), 3(c), 3(c)(7) · Duration One year or less · Revenue Not Applicable | ||||
| VC | Atlas Venture Fund XIII LP | [2023-03-31] | 450.0 M | 551.4 M |
| Offered $450,000,000 · Filed 2022-03-03 (D) · Exemption 506(b), 3(c), 3(c)(7) · Duration One year or less · Revenue Not Applicable | ||||
| VC | Atlas Venture Opportunity Fund II LP | [2022-03-31] | 300.0 M | 287.4 M |
| Offered $300,000,000 · Filed 2021-10-01 (D) · Exemption 506(b), 3(c), 3(c)(7) · Duration One year or less · Revenue Not Applicable | ||||
| VC | Atlas Venture Fund XII LP | [2021-06-08] | 400.0 M | 318.2 M |
| Offered $400,000,000 · Filed 2020-06-04 (D) · Exemption 506(b), 3(c), 3(c)(7) · Duration One year or less · Revenue Not Applicable | ||||
| VC | Atlas Venture Opportunity Fund I LP | [2019-03-29] | 250.0 M | 164.0 M |
| Offered $250,000,000 · Filed 2019-01-02 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Duration One year or less · Revenue Not Applicable | ||||
| VC | Atlas Venture Fund Xi LP | [2018-03-30] | 350.0 M | 340.2 M |
| Offered $350,000,000 · Filed 2017-06-30 (D) · Exemption 506(b), 3(c), 3(c)(7) · Duration One year or less · Revenue Not Applicable | ||||
| VC | Atlas Venture Fund X LP | [2015-02-19] | 490.8 M | |
| Offered $250,000,000 · Filed 2014-12-18 (D) · Exemption 506(b), 3(c), 3(c)(7) · Remaining $250,000,000 · Duration One year or less · Revenue Not Applicable | ||||
| AUM Breakdown | Accounts | AUM ($) |
|---|---|---|
| By Client Type | ||
| (a) Individuals (other than high net worth individuals) | 0 | 0.0 |
| (b) Individuals (high net worth individuals) | 0 | 0.0 |
| (c) Banking or thrift institutions | 0 | 0.0 |
| (d) Investment companies | 0 | 0.0 |
| (e) Business development companies | 0 | 0.0 |
| (f) Pooled investment vehicles | 0 | 0.0 |
| (g) Pension and profit sharing plans | 0 | 0.0 |
| (h) Charitable organizations | 0 | 0.0 |
| (i) State or municipal government entities | 0 | 0.0 |
| (j) Other investment advisers | 0 | 0.0 |
| (k) Insurance companies | 0 | 0.0 |
| (l) Sovereign wealth funds and foreign official institutions | 0 | 0.0 |
| (m) Corporations or other businesses not listed above | 0 | 0.0 |
| (n) Other | 0 | 0.0 |
| Total | 0 | 0.0 |
| By Discretionary | ||
| Discretionary | 0 | 0.0 |
| Non-Discretionary | 0 | 0.0 |
| Total | 0 | 0.0 |
| By Non-United States Persons | ||
| Non-United States Persons | 0.0 | |
| United States Persons | 0.0 | |
| Total | 0 | 0.0 |
| Form D Directors | Role | # Filings | # Firms | 2011 - 2026 |
|---|---|---|---|---|
| Peter Barrett | Executive Officer | 56 | 3 | |
| Kevin Bitterman | Executive Officer | 49 | 2 | |
| Jean-Francois Formela | Executive Officer | 41 | 2 | |
| Bruce Booth | Executive Officer | 40 | 2 | |
| David Grayzel | Executive Officer | 21 | 2 | |
| Jason Rhodes | Executive Officer | 12 | 2 | |
| Michael Gladstone | Executive Officer | 8 | 2 | |
| Atlas Venture Associates X LP | Executive Officer | 1 | 1 | |
| Atlas Venture Associates XIV LLC | Executive Officer | 1 | 1 | |
| Atlas Venture Associates XII LLC | Executive Officer | 1 | 1 | |
| View All | ||||
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 13F-HR | [0001917529] |